Correlation Between Enliven Therapeutics and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Monte Rosa.
Diversification Opportunities for Enliven Therapeutics and Monte Rosa
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Enliven and Monte is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Monte Rosa go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Monte Rosa
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.82 times less risky than Monte Rosa. The stock trades about -0.23 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 948.00 in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would lose (102.00) from holding Monte Rosa Therapeutics or give up 10.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| Monte Rosa Therapeutics |
Enliven Therapeutics and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Monte Rosa
The main advantage of trading using opposite Enliven Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |